SEC Form 4 · accession 0001179110-15-014746
USANA HEALTH SCIENCES INC · USNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rick Stambaugh
Officer — Chief Information Officer
Period of report
Nov 9, 2015
Accepted (ET)
Nov 12, 2015 · 11:29 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896264
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 9, 2015 | M | 1,000 | $45.91 | A | 1,000 | D | |
| Common Stock | Nov 9, 2015 | S | 1,000 | $135.00 | D | 0 | D | |
| Common StockF1 | Nov 9, 2015 | M | 2,053 | $45.91 | A | 2,053 | D | |
| Common StockF2 | Nov 9, 2015 | S | 2,053 | $130.2384 | D | 0 | D | |
| Common StockF1 | Nov 10, 2015 | M | 200 | $45.91 | A | 200 | D | |
| Common Stock | Nov 10, 2015 | S | 200 | $130.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-Settled Stock Appreciations Rights | $45.91 | Nov 9, 2015 | M | 1,516 | D | Oct 22, 2017 | Apr 22, 2018 | Common Stock | 1,516 | 13,484 | D |
| Stock-Settled Stock Appreciations Rights | $45.91 | Nov 9, 2015 | M | 3,174 | D | Oct 22, 2017 | Apr 22, 2018 | Common Stock | 3,174 | 10,310 | D |
| Stock-Settled Stock Appreciations Rights | $45.91 | Nov 10, 2015 | M | 310 | D | Oct 22, 2017 | Apr 22, 2018 | Common Stock | 310 | 10,000 | D |
Explanation of responses
- F1The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
- F2Weighted average price. Price range in multiple transactions was $130.00 to $130.51, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.